Magnesium VitB6 intake reduces central nervous system hyperexcitability in children

Marianne Mousain-Bosc1, Michele Roche, Jean Rapin

  • 1Department of Pediatry, CHU Nimes, 30029 Nimes Cedex, France.

Abstract

Insights

Hyperexcitable children often have low intracellular magnesium (Mg2+) levels, even with normal serum concentrations. Supplementation with magnesium (Mg2+) and vitamin B6 effectively improved behavior and restored normal Mg2+ levels in these children.

Area of Science:

  • Pediatric Neurology
  • Nutritional Neuroscience
  • Biochemistry

Background:

  • Ionic magnesium (Mg2+) depletion is linked to hyperexcitability and seizures in rodents.
  • Metabolic and genetic factors may influence Mg2+ transport and intracellular distribution, independent of serum Mg2+ levels.

Observation:

  • This study evaluated 52 hyperexcitable children under 15 years old and their families.
  • Intra-erythrocyte Mg2+ levels (ERC-Mg) were measured to assess intracellular Mg2+ status.
  • Low ERC-Mg values were observed in 30 of the 52 children.

Findings:

  • Combined Mg2+/vitamin B6 supplementation (100 mg/day) for 3-24 weeks normalized ERC-Mg levels.
  • Treatment significantly reduced symptoms of hyperexcitability, including aggressivity, instability, and attention deficits.
  • Affected family members also showed low ERC-Mg and responded to Mg2+/vitamin B6 supplementation.

Implications:

  • Hyperexcitable children may present with intracellular Mg2+ deficiency, distinct from serum Mg2+ levels.
  • Mg2+/vitamin B6 supplementation offers a potential therapeutic strategy for improving behavior in these children.
  • This highlights the importance of intracellular Mg2+ status in pediatric behavioral disorders.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.